The overall objectives of the Animal Core are to provide animals to the various projects in the Center, and to organize and store tissue from non-human primates as needed by the projects in the Center. Many of the projects described in this grant will use animal models of self-administration to study long-term neuroadaptations as a consequence of exposure to drugs of abuse. Rats will be trained to self-administer cocaine, heroin, or cocaine and heroin (speedball) for varying lengths of time under different schedule conditions coupled with various periods of deprivation, in addition, rats treated with novel irreversible ligands at the monoamine transporters will be studied behaviorally in locomotor activity studies and prepared for autoradiographic analysis. Finally, the Animal Core will be responsible for proper sacrifice, brain collection, tissue storage, and redistribution of brains from non-human primates used in various projects, when necessary. The specific goals of the Animal Core are as follows: 1. Provide experimental animals to subprojects 0001, 0008, 0011, and 0012 that have particular histories of self-administration and deprivation. 2. Examine the locomotor-altering effects of novel compounds (administered i.c.v.) produced by the Chemistry Core. 3. Provide subjects that have been treated with these novel compounds (administered i.c.v.) to subproject 0001 for autoradiographic analysis. 4. Collect and store brain tissue from non-human primates (from subprojects 0012, 0003, and 0009) when the need arises, and redistribute the tissue to subprojects for neurobiological investigation.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA006634-16
Application #
7390847
Study Section
Special Emphasis Panel (ZDA1)
Project Start
2007-04-01
Project End
2009-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
16
Fiscal Year
2007
Total Cost
$160,551
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Siciliano, Cody A; Saha, Kaustuv; Calipari, Erin S et al. (2018) Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation. J Neurosci 38:484-497
Ilyasov, Alexander A; Milligan, Carolanne E; Pharr, Emily P et al. (2018) The Endocannabinoid System and Oligodendrocytes in Health and Disease. Front Neurosci 12:733
Ding, Huiping; Kiguchi, Norikazu; Yasuda, Dennis et al. (2018) A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med 10:
Chen, R; McIntosh, S; Hemby, S E et al. (2018) High and low doses of cocaine intake are differentially regulated by dopamine D2 receptors in the ventral tegmental area and the nucleus accumbens. Neurosci Lett 671:133-139
John, William S; Martin, Thomas J; Solingapuram Sai, Kiran Kumar et al. (2018) Chronic ?9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability. J Pharmacol Exp Ther 364:300-310
Raab-Graham, Kimberly F; Niere, Farr (2017) mTOR referees memory and disease through mRNA repression and competition. FEBS Lett 591:1540-1554
Howlett, Allyn C; Abood, Mary E (2017) CB1 and CB2 Receptor Pharmacology. Adv Pharmacol 80:169-206
Deadwyler, Sam A; Hampson, Robert E; Song, Dong et al. (2017) A cognitive prosthesis for memory facilitation by closed-loop functional ensemble stimulation of hippocampal neurons in primate brain. Exp Neurol 287:452-460
John, William S; Nader, Michael A (2017) Effects of ethanol on cocaine self-administration in monkeys responding under a second-order schedule of reinforcement. Drug Alcohol Depend 170:112-119
Blume, Lawrence C; Patten, Theresa; Eldeeb, Khalil et al. (2017) Cannabinoid Receptor Interacting Protein 1a Competition with ?-Arrestin for CB1 Receptor Binding Sites. Mol Pharmacol 91:75-86

Showing the most recent 10 out of 310 publications